Compare Harmony Gold Mining Co. (HMY) vs Organon & Co. Common Stock (OGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Harmony Gold Mining Co. vs Organon & Co. Common Stock — how do they compare? Harmony Gold Mining Co. trades at $16.86 (market cap $10.25B), while Organon & Co. Common Stock trades at $13.73 (market cap $3.61B). The key difference: Harmony Gold Mining Co. is far larger — about 2.8× Organon & Co. Common Stock's market cap, and Harmony Gold Mining Co. pays the higher dividend (4.79%). Which is the better fit depends on your goals — on Pluang, investors hold Harmony Gold Mining Co. for 45 Days and Organon & Co. Common Stock for 0 Days on average.
| HMY | OGN | |
|---|---|---|
Market Cap | $10.25B | $3.61B |
Volume | 3,439,062 | 1,808,049 |
Sector | Basic Materials | Health |
52-Week High | $26.04 | $13.81 |
52-Week Low | $13.32 | $5.70 |
Typical Hold Time | 45 Days | 0 Days |
Enterprise Value | $10.30B | $11.03B |
Dividend Yield | 4.79% | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Harmony Gold Mining (HMY) trades at $16.71, up 0.18% on the day, with a bearish technical signal despite strong fundamentals. The company reported record fiscal 2026 results with revenue reaching $99.2B and net income of $29.3B, driven by higher gold prices and copper expansion. Valuation metrics remain attractive with P/E of 5.96 and EV/EBITDA of 3.64, while profitability metrics show robust ROE of 46.23% and net margin of 29.57%.
HMY presents a compelling value opportunity with strong cash flow generation and strategic copper diversification, though technical weakness and mixed analyst sentiment (70% hold rating) suggest near-term caution. Key risks include commodity price volatility and execution of copper expansion plans, while the current valuation discount to historical levels offers potential upside for patient investors.
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Harmony Gold Mining Co.
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.
Read more on HMY →About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →
